Kurse werden geladen...
Prognose
| Kaufen | 3 |
| Halten | 2 |
| Verkaufen | 0 |
Scoring-Modelle
| Dividenden-Strategie | 5 / 15 |
| HGI-Strategie | 2 / 18 |
| Levermann-Strategie | 2 / 13 |
News
Alto Neuroscience Highlights Peer-Reviewed Publication of PAX-D Study in The Lancet Psychiatry Demonstrating Robust Clinical Effects of Pramipexole for Patients with Treatment-Resistant Depression
MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)---- $ANRO #PrecisionPsychiatry--Alto Neuroscience, Inc. (“Alto”) (NYSE: ANRO) a clinical-stage biopharmaceutical company focused on the development of novel precision medicines for neuropsychiatric disorders, today highlighted The Lancet Psychiatry publication of data from the PAX-D study evaluating pramipexole in patients with treatment-resistant depression (TRD). The study was conducted by the University of Oxford and was funded by the UK government's National Institute for Health and.» Mehr auf businesswire.com
My Biggest Investment For 2025: An Update On Patria Investments
Patria Investments is finally getting some love. But even after its recent surge, it remains deeply undervalued. I expect a lot more upside. Here is why.» Mehr auf seekingalpha.com
Rare Buying Opportunities: 2 Top Picks Set To Soar
Investors looking for quality businesses with strong balance sheets typically have to choose between growth and yield. However, on rare occasions, Mr. Market offers quality opportunities that provide both yield and growth. We share 2 of some of our top picks of the moment that combine these traits and appear set to soar.» Mehr auf seekingalpha.com
Historische Dividenden
Alle Dividenden KennzahlenUnternehmenszahlen
| (EUR) | März 2025 | |
|---|---|---|
| Umsatz | 73,67 Mio | 24,86% |
| Bruttoeinkommen | 48,62 Mio | 2,92% |
| Nettoeinkommen | 12,57 Mio | 12,18% |
| EBITDA | 37,53 Mio | 26,71% |
Fundamentaldaten
| Metrik | Wert |
|---|---|
Marktkapitalisierung | 1,92 Mrd€ |
Anzahl Aktien | 158,08 Mio |
52 Wochen-Hoch/Tief | 12,18€ - 7,99€ |
Dividendenrendite | 4,49% |
Dividenden TTM | 0,54€ |
Beta | 0,67 |
KGV (PE Ratio) | 31,09 |
KGWV (PEG Ratio) | −7,62 |
KBV (PB Ratio) | 4,11 |
KUV (PS Ratio) | 5,80 |
Unternehmensprofil
Patria Investments Limited ist eine private Investmentgesellschaft, die sich auf Investitionen in Lateinamerika konzentriert. Das Unternehmen bietet Anlegern Vermögensverwaltungsdienste mit Schwerpunkt auf Private-Equity-Fonds, Infrastrukturentwicklungsfonds, Ko-Investitionsfonds, konstruktivistischen Aktienfonds sowie Immobilien- und Kreditfonds. Patria Investments Limited wurde 1994 gegründet und hat seinen Hauptsitz in Grand Cayman auf den Cayman-Inseln.
| Name | Patria Investments |
| CEO | Alexandre Teixeira de Assumpcao Saigh |
| Sitz | Grand Cayman, Cayman Islands |
| Website | |
| Industrie | Kapitalmärkte |
| Börsengang | |
| Mitarbeiter | 577 |
Ticker Symbole
| Börse | Symbol |
|---|---|
NASDAQ | PAX |
Assets entdecken
Shareholder von Patria Investments investieren auch in folgende Assets
